Latest News and Press Releases
Want to stay updated on the latest news?
-
Certified investor class alleged InnovAge’s IPO registration statement was materially false and misleading, prompting a 78% stock drop.
-
Zenas BioPharma investors have until June 16 to sign up to become a Lead Plaintiff in this securities class action. For more information, call Molly Bowen.